The Juvenile Diabetes Research Foundation, the world?s largest charitable funder of type 1 diabetes research, praised today?s historic vote in the U.S. Senate to expand federal funding for embryonic stem cell research with the passage of S. 5, the Stem Cell Research Enhancement Act of 2007.
A Northwestern University researcher has used adult stem cell injections to reset the immune systems of patients with early-onset Type 1 diabetes. After the therapy, patients no longer needed to take insulin for up to 35 months.
A therapy that includes stem cell transplantation induced extended insulin independence in patients with type 1 diabetes mellitus, according to a preliminary study in the April 11 issue of JAMA.
Data demonstrating genetic differences in individuals? susceptibility to certain cancers as well as differences in how people respond to specific cancer treatments will take center stage when more than 17,000 scientists from around the world gather at the Los Angeles Convention Center April 14-18 for the 2007 Annual Meeting of the American Association for Cancer Research (AACR). Key data presented at the meeting will also include findings related to the safety and effectiveness of several new, high-profile cancer therapies and vaccines.
Female stem cells derived from muscle have a greater ability to regenerate skeletal muscle tissue than male cells, according to a study at Children?s Hospital of Pittsburgh of UPMC.
The U.S. Patent and Trademark Office has upheld challenges by consumer advocates to three over-reaching patents on human embryonic stem cells and rejected patent claims by the Wisconsin Alumni Research Foundation (WARF), the Foundation for Taxpayer and Consumer Rights (FTCR) said.
Have you ever walked by someone listening to their i-Pod loud enough for you recognize the song? Studies have shown noise-induced hearing loss is going to become the next big epidemic affecting our younger generation though the effects won?t show until it is too late to treat.
In the event of a nuclear or radiological catastrophe — such as a nuclear accident or a ?dirty bomb? — thousands of people would be exposed to radiation, with no way of quickly determining how much of the deadly substance has seeped inside their bodies.
The CNS Foundation welcomes the publication by CNS grantee Dr. Evan Snyder of experimental results that extend the promise of stem cell therapies to degenerative brain diseases of childhood.
For the millions of Americans whose vision is slowly ebbing due to degenerative diseases of the eye, the lowly neural progenitor cell may be riding to the rescue.